November 2025 Webinar
IES Congress Highlights
Tuesday, 11 November 2025
11:00 am - 12:30 pm US Eastern / 5:00 pm - 6:30 pm Central Europe
Join us for the IES Congress Highlights webinar, featuring select presentations from the 13th Biennial International Eosinophil Society Congress, held in Montpellier, France, from 7–11 July 2025. This session offers an opportunity to revisit several of the most highly rated scientific talks from the meeting, whether you missed them during the Congress or would like to view them again. The program showcases the exceptional science and record attendance that made this year’s Congress one of the most successful in IES history.
Our live webinars are completely free of charge, we just ask that you register in advance. Webinars are hosted on Zoom and audience members can ask questions using the Q&A feature. Real-time closed captioning is available for those with hearing impairments.
Program
11:00 am – 11:10 am: Introduction and Welcome
Allison Fryer - United States & Nicola Diny - Germany
11:10 am – 11:30 am: Regulation of the Eosinophil Lineage in Eosinophil-Associated Diseases in the Context of Precision Therapy
Christophe Desmet - Belgium
11:30 am – 11:35 am: Audience Q&A
11:35 am – 11:55 am: Transcriptional and Epigenetic Regulation of Eosinophil Development, Maturation and Tissue Specificity: Promoters, Enhancers and Beyond
Jennifer Felton - United States
11:55 am – 12:00 pm: Audience Q&A
12:00 pm – 12:20 pm: Relationship Between Genetic Variants that Regulate Blood Eosinophilia and Allergic Disease Risk
Leah Kottyan - United States
12:20 pm – 12:25 pm: Audience Q&A
12:25 pm – 12:30 pm: Closing Remarks
Speakers & Moderators
|
Christophe Desmet |
Christophe Desmet is a molecular biologist at the GIGA Institute of the University of Liege in Belgium. He specializes in the regulation of myeloid cell plasticity and function during hematopoiesis and within tissues, with a particular interest for eosinophils and their impact in the respiratory tract. |
|
Jennifer Felton |
Dr. Felton is a Senior Research Associate in the Rothenberg CURED Lab at Cincinnati Children's Hospital. Her work focuses on investigating the transcriptional and epigenetic factors that influence the process of eosinophil development and tissue specificity, primarily in the context of the esophagus (Eosinophilic Esophagitis) and gastrointestinal tract. She joined the Rothenberg CURED lab in 2018 after completing her PhD in Inflammation Research at the University of Edinburgh, where she investigated the regulation of eosinophil death and clearance in the resolution of allergic airway disease. |
|
Leah Kottyan |
Leah Kottyan, PhD, is a Professor at Cincinnati Children's Hospital Medical Center and the University of Cincinnati, where she leads a National Institutes of Health-funded research laboratory focused on the genetic etiology of immune diseases such as eosinophilic esophagitis and systemic lupus erethamatosus. Dr. Kottyan also serves as the leader of the Cincinnati Children's Basic Science Research Committee, which represents hundreds of faculty members conducting foundational research to discover new biological insights. Her research includes the discovery of genotype-dependent disease risk mechanisms and studies on the clinical return of individualized polygenic disease risk. |
|
Allison Fryer |
Dr. Allison Fryer has demonstrated that eosinophils are actively recruited to airway nerves where they change nerve architecture, neurotransmitter content and neurotransmitter release in allergic, infectious, and environmental models of asthma. Her research was foundational to the now, widely accepted, tenet that neuroimmune interactions contribute to chronic inflammatory diseases. Dr. Fryer’s research is published in over 115 peer reviewed papers and book chapters. She is a Fellow of the British Pharmacological Society. She served as an editor for the British Journal of Pharmacology and for the American Journal Respiratory and Critical Care Medicine. Dr. Fryer has trained 16 PhD students and 14 postdoctoral fellows, many of whom are now leaders in academia and industry. She is currently Associate Dean for Graduate Studies in the School of Medicine at Oregon Health & Science University. A member of the International Eosinophil Society for many years, she has served on the steering committee since 2018, and led the scientific committee that planned the 2019 IES meeting in Portland. |
|
Nicola Diny |
Nicola Diny obtained her PhD from Johns Hopkins University working on the role of eosinophils as drivers of inflammation and chronic adverse remodelling of the heart. She continued to study eosinophils, focusing on homeostatic tissue functions and tissue adaptation at the Francis Crick Institute. Here, Dr. Diny discovered that the aryl hydrocarbon receptor drives adaptation of eosinophils to the local tissue environment in the small intestine. In 2023, she moved to the University of Bonn to start a Junior Research Group focused on eosinophil tissue adaptation and function. |
